First Citizens Bank & Trust 13F: Adds $5.9M to JNJ Stake
The bank raised its holdings in Johnson & Johnson by 71.8%, now holding 52,947 shares.
Reviewed by automated data checks against the source filing. How we make and check alerts
First Citizens Bank & Trust added 22,136 shares to its stake in Johnson & Johnson ($JNJ), a 71.84% increase, according to a 13F filing with the SEC dated October 14, 2026. It reported 52,947 shares worth $14.02 million at the end of the quarter.
Since the filing, $JNJ is up 0.7% to date (from the $253.91 close on Oct 14, 2026).
Find the original: First Citizens Bank & Trust 13F filings on SEC EDGAR
Key Points
- First Citizens Bank & Trust increased its stake in Johnson & Johnson by 71.8%, adding 22,136 shares, bringing its total to 52,947 shares valued at $14.02 million.
- Johnson & Johnson, a healthcare giant, has a market cap of $610.4 billion, a P/E ratio of 38.4, and a 52-week high of $281.07.
- Johnson & Johnson offers a 2.12% dividend yield, with a payout ratio of 60.72%, and analysts have a 'buy' recommendation with a mean price target of $279.41.
Get $JNJ trade alerts by text
We text you when insiders, Congress or big funds trade $JNJ. Free.
Not investment advice. EarningsIQ is not a registered investment adviser, and this automated Johnson & Johnson alert may contain errors. Disclosures
First Citizens Bank & Trust has significantly increased its investment in Johnson & Johnson (NYSE: JNJ). According to the latest Form 13F filing with the SEC, the bank added 22,136 shares, boosting its holdings by 71.8% to a total of 52,947 shares. The value of this increased position is approximately $14.02 million.
First Citizens Bank & Trust vs. the S&P 500
Hypothetical returns from First Citizens Bank & Trust's disclosed trades, not real profit or advice. How we model this.
What Changed in First Citizens Bank & Trust's Johnson & Johnson Position
First Citizens Bank & Trust's latest move shows a strong vote of confidence in Johnson & Johnson. Previously holding 30,811 shares, the bank increased its holdings by 22,136 shares, reaching a total of 52,947 shares. The reported value of this investment stands at $14.02 million, reflecting a significant increase in their stake.
Johnson & Johnson Stock Up 0.6%
Shares of Johnson & Johnson traded near their previous close of $253.91 on Friday. The company, with a market cap of approximately $610.4 billion, has a P/E ratio of 38.4 and a forward P/E of 21.6. Its beta is a low 0.206, indicating relatively low volatility. The stock has seen a 52-week low of $184.66 and a high of $281.07, with a 50-day moving average of $265.26 and a 200-day moving average of $243.87.
Recent Earnings
In its recent earnings report, Johnson & Johnson posted revenue of $99.33 billion, with a revenue growth of 5.9%. The company's net margin was 16.2%, and it recorded earnings per share (EPS) of $6.59. The next earnings announcement is expected on January 26, 2027.
Dividend
Johnson & Johnson offers a dividend yield of 2.12%, with an annual payout ratio of 60.72%. This makes it an attractive option for income-focused investors.
About Johnson & Johnson
Johnson & Johnson is a global leader in healthcare products, headquartered in New Brunswick, New Jersey. The company operates in two primary segments: Innovative Medicine and MedTech. It develops, manufactures, and sells a wide range of products, including pharmaceuticals, medical devices, and consumer health products. With over 138,200 employees worldwide, Johnson & Johnson is led by CEO Mr. Joaquin Duato.
Bottom Line
First Citizens Bank & Trust's increased investment in Johnson & Johnson underscores its confidence in the company's prospects. Investors often track such institutional moves for insights on market sentiment. It's important to remember that 13F filings are historical and may not represent current positions.
Source: First Citizens Bank & Trust's 13F filing on $JNJ (Oct 14, 2026). 13F filings show holdings as of the end of the reporting quarter and may not reflect the fund's current position. Find the original filing: First Citizens Bank & Trust 13F filings on SEC EDGAR. Written by software, not financial advice. How we make alerts
